Beclometasone/formoterol/glycopyrronium pMDI for severe asthma

Description

In this Product Explainer, Respiratory Physician Dr Andrew Scroop explains the role of beclometasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment in adult patients with uncontrolled asthma despite treatment with an ICS and a LABA with a history of exacerbations (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Nicole Goh

A/Prof Nicole Goh

Detection, Assessment and Management of Pulmonary Fibrosis

A/Prof Robyn Saw

A/Prof Robyn Saw

Practical Melanoma Management for GPs

Dr Bobby Chan

Dr Bobby Chan

Preventing Renal Failure in Type 2 Diabetes – New Options

Dr Victoria Hayes

Dr Victoria Hayes

Management of Post-Vaccination Reactions

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Andrew Scroop

expert

Dr Andrew Scroop

Respiratory Physician; Founding Director of Respiratory Consultants, St Andrews Medical Centre

Date published: 24 January 2025